Výsledky vyhledávání

Pro-gastrin-releasing peptide(31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase

Autor: Yoko Kusunoki, K Iida, N Kikui, Masahiro Fukuoka, Kenji Tamura, H Morino, Takashi Yana, M Takada, S Ushijima, Ichiro Kawase, Takefumi Komiya, N Masuda, K Matui

Publikováno v: British Journal of Cancer

We attempted to clarify whether serum levels of a carboxy-terminal fragment of ProGRP, ProGRP(31-98), could serve as a more accurate tumour marker in patients with SCLC than neuron-specific enolase (NSE). ProGRP(31-98) and NSE were measured retrospec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed4b167c1b7f43aac9fe73cd5b370151
https://doi.org/10.1038/bjc.1996.235

Zobrazit plný text záznamu

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay

Autor: Takashi Yana, M Takada, E Matsuura, Yoko Kusunoki, K Matui, I Oohata, Masahiro Fukuoka, Kazuhiko Nakagawa, I Tuyuguchi, N Masuda

Publikováno v: British Journal of Cancer

Soluble cytokeratin fragment 19 levels were measured with an enzyme immunoassay method developed by Boehringer Mannheim (Enzymun-Test CYFRA 21-1) in the serum of 185 patients with lung cancer [149 with non-small-cell lung cancer (NSCLC) and 36 with s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81487d7af3cce39cf4d2b2ca440cce1f
https://doi.org/10.1038/bjc.1995.33

Zobrazit plný text záznamu

Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer

Autor: T, Hirashima, T, Komiya, T, Nitta, Y, Takada, M, Kobayashi, N, Masuda, K, Matui, M, Takada, M, Kikui, T, Yasumitu, A, Ohno, K, Nakagawa, M, Fukuoka, I, Kawase

Publikováno v: Anticancer research. 20(3B)

This study was performed to evaluate the prognostic significance of alteration in telomere length in pathological stage (p-stage) I-IIIA non-small cell lung cancer (NSCLC). Paired cancer and normal lung tissues were obtained from 72 patients with his

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1f97b645f37f945d6c15383c0f99488d
https://pubmed.ncbi.nlm.nih.gov/10928174

Zobrazit plný text záznamu

Prognostic significance of CYFRA 21-1 in non-small cell lung cancer

Autor: T, Hirashima, M, Takada, T, Komiya, T, Nitta, K, Masashi, N, Masuda, K, Matui, M, Kikui, T, Yasumitsu, I, Kawase

Publikováno v: Anticancer research. 18(6B)

Between July 1991 and February 1993, CYFRA 21-1 levels of 149 newly diagnosed patients with histologically proven non-small cell lung cancer (NSCLC) at Osaka Prefectural Habikino Hospital were measured with an enzyme immunoassay method developed by B

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::baae4710dda1ef52e4d2ebb2813565fb
https://pubmed.ncbi.nlm.nih.gov/9891546

Zobrazit plný text záznamu

A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma

Autor: M, Kawahara, K, Furuse, N, Kodama, M, Yamamoto, K, Kubota, M, Takada, S, Negoro, Y, Kusunoki, K, Matui, N, Takifuji

Publikováno v: Cancer. 68(4)

Between August 1983 and March 1985, a randomized study was conducted that compared cisplatin (CDDP) (80 mg/m2 on day 1) alone with CDDP plus vindesine (VDS) (3 mg/m2 on days 1, 8, and 15) in 160 consecutive patients with inoperable non-small cell lun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7c3ea8142f225f9670bc7a85e3c693b7
https://pubmed.ncbi.nlm.nih.gov/1649683

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání